awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38616424-0F77C92F-BA20-4075-8378-A85482EF44B9
Q38616424-0F77C92F-BA20-4075-8378-A85482EF44B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38616424-0F77C92F-BA20-4075-8378-A85482EF44B9
Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.
P2860
Q38616424-0F77C92F-BA20-4075-8378-A85482EF44B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38616424-0F77C92F-BA20-4075-8378-A85482EF44B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ea8f7dddf7d7ce8dd939af05dcd2fa8e269ba323
P2860
Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.